Related Experiment Video
Updated: Sep 4, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency
Jan Niederdöckl1, Julia Oppenauer1, Sebastian Schnaubelt1
1Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.
Insights
The ABC-stroke score outperforms the CHA2DS2-VASc score in predicting stroke risk for atrial fibrillation patients in emergency settings. ABC-stroke offers better risk stratification, aiding treatment decisions for moderate-risk patients.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Prediction Models
Background:
- Atrial fibrillation (AF) is a common cause of stroke.
- Accurate stroke risk stratification is crucial for guiding anticoagulation therapy in AF patients.
- Existing scores like CHA2DS2-VASc have limitations in real-world emergency settings.
Purpose of the Study:
- To prospectively evaluate the performance of the ABC (Age, Biomarkers, Clinical history)-stroke score and the CHA2DS2-VASc score for stroke risk assessment in an emergency department.
- To compare the predictive accuracy and risk stratification capabilities of both scores in a real-world cohort of acute symptomatic AF patients.
Main Methods:
- Prospective evaluation of 2,108 consecutive patients with acute symptomatic AF in a tertiary care emergency department.
- Assessment of stroke incidence over 3,686 person-years.
- Comparison of predictive performance using c-indices and hazard ratios, along with decision curve analysis.
Main Results:
- The ABC-stroke score demonstrated a higher c-index (0.64) compared to CHA2DS2-VASc (0.55) for stroke prediction.
- ABC-stroke showed significantly better risk stratification, with higher hazard ratios for moderate-to-low (3.51) and high-to-low (2.56) risk comparisons.
- ABC-stroke improved risk stratification in CHA2DS2-VASc moderate-risk patients (HR: 4.35, P = 0.001), who often lack clear anticoagulation guidance.
Conclusions:
- The ABC-stroke score is superior to the CHA2DS2-VASc score in predicting stroke risk in acute AF patients within an emergency setting.
- ABC-stroke provides enhanced risk stratification, particularly for patients classified as moderate risk by CHA2DS2-VASc, potentially simplifying treatment decisions.
Aims:
To evaluate the performance of the ABC (Age, Biomarkers, Clinical history) and CHA2DS2-VASc stroke scores under real-world conditions in an emergency setting.
Methods And Results:
The performance of the biomarker-based ABC-stroke score and the clinical variable-based CHA2DS2-VASc score for stroke risk assessment were prospectively evaluated in a consecutive series of 2,108 patients with acute symptomatic atrial fibrillation at a tertiary care emergency department. Performance was assessed according to methods for the development and validation of clinical prediction models by Steyerberg et al. and the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis. During a cumulative observation period of 3,686 person-years, the stroke incidence rate was 1.66 per 100 person-years. Overall, the ABC-stroke and CHA2DS2-VASc scores revealed respective c-indices of 0.64 and 0.55 for stroke prediction. Risk-class hazard ratios comparing moderate to low and high to low were 3.51 and 2.56 for the ABC-stroke score and 1.10 and 1.62 for the CHA2DS2-VASc score. The ABC-stroke score also provided improved risk stratification in patients with moderate stroke risk according to the CHA2DS2-VASc score, who lack clear recommendations regarding anticoagulation therapy (HR: 4.35, P = 0.001). Decision curve analysis indicated a superior net clinical benefit of using the ABC-stroke score.
Conclusion:
In a large, real-world cohort of patients with acute atrial fibrillation in the emergency department, the ABC-stroke score was superior to the guideline-recommended CHA2DS2-VASc score at predicting stroke risk and refined risk stratification of patients labeled moderate risk by the CHA2DS2-VASc score, potentially easing treatment decision-making.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:23Cardiopulmonary Resuscitation III: AED Use
01:23Atherosclerosis IV: Nursing Management